Health · 1 sources covering this

STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

The FDA approved a treatment for advanced multiple myeloma made by Bristol Myers Squibb, marking the debut of a new class of drugs for the blood cancer.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·2h ago
STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class
The FDA approved a treatment for advanced multiple myeloma made by Bristol Myers Squibb, marking the debut of a new class of drugs for the blood cancer.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/505a523924352a11334cac62487333a2ec652490"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class"></iframe>

STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

How 1 sources are covering this

STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

More from Health

STAT+: Drug-testing lab that has sparked controversy sues group that develops drug standards over criticism

My Husband Was Kicked Out of Hospice for Dying Too Slowly

Trump Team’s Use of Arcane Budget Rule Threatens Medicaid Coverage

Record cyclosporiasis outbreak tests agencies hit by Trump administration's cuts

Reader

Trust & legal

Across the network